Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smith & Nephew Inks Osteotech For DBM, Launches Varicose Vein Remover

This article was originally published in The Gray Sheet

Executive Summary

Smith & Nephew will enter the demineralized bone matrix (DBM) market in the third quarter through a distribution deal with Osteotech

You may also be interested in...

Biomet’s Interpore Purchase Creates $200 Mil. Spinal Devices Business

Biomet will expand its spinal franchise by nearly one third and gain artificial disc technology via the $280 mil. cash acquisition of Interpore, announced March 8

Licensees Sought For Osteotech Grafton DBM; Firm Cuts Workforce By 5%

Osteotech aims to improve domestic sales of its Grafton demineralized bone matrix business by initiating licensing deals with large orthopedic players

Unilever Hit With Class Action Over Mercury-Laced Pond’s Cream Originating In Mexico

According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts